Clin2
NCT06448195Possibly a fitRecruiting

Growth Hormone for Fatty Liver After Pituitary Surgery

Growth Hormone Treatment

Part of Hormones & metabolism clinical trials.

This trial tests whether growth hormone therapy can improve liver health and metabolic function in people who have fatty liver after pituitary tumor surgery. It is for adults with growth hormone deficiency who have excess fat in their liver.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You have been diagnosed with growth hormone deficiency after pituitary tumor surgery.
  • A special liver scan (1H MRS) showed that more than 11% of your liver is fatty, and this scan was done between 6 months and 2 years after your surgery.
  • You do not have other liver diseases like hepatitis, cirrhosis, or alcoholic liver disease.
  • Your blood pressure is below 150/95 mmHg and you are not taking any blood pressure medication.
  • You are not taking any cholesterol-lowering medication (like statins) and your diabetes, if you have it, is well controlled (HbA1c below 9.5%).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06037473Recruiting
PEG growth hormone for short stature in children

This trial tests if a long-acting growth hormone (PEGylated GH) helps children with various causes of short stature grow taller. It may be an option if your child has a condition like growth hormone deficiency, Turner syndrome, or idiopathic short stature.

Beijing, Beijing Municipality
NCT05144035Recruiting· Phase 4
Early growth-hormone treatment for small baby’s brain development

This study tests whether starting a growth hormone treatment early helps a baby’s thinking and learning development. It is for babies who are small for their gestational age and show delays on a developmental screening test.

Wuhan, Wuhan
NCT06803589Recruiting· Early Phase 1
Growth hormone for hard-to-treat stomach paralysis

This study tests if growth hormone can help people with long-term stomach paralysis (gastroparesis) that hasn't improved with standard care. It looks at whether the treatment reduces symptoms like nausea and feeling full too quickly.

Phoenix, Arizona
NCT07778719Not yet recruiting
Metformin and dapagliflozin effect on growth factor in men with type 2 diabetes and fatty liver

This trial tests whether adding dapagliflozin to metformin affects a hormone called IGF-1, which is linked to growth and metabolism. It may help men with type 2 diabetes and fatty liver disease understand if this combination can improve their condition.

Putian, Fujian
NCT06110910Recruiting
Growth hormone study for children with short stature

This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.

Wuhan, Hubei
NCT05355272Recruiting· Phase 2
Growth hormone treatment for Gulf War illness with low growth hormone

This Phase 2 study tests whether replacing growth hormone can improve symptoms in veterans with Gulf War Illness and adult growth hormone deficiency. It also checks that the treatment is safe for people with stable medications and hormone regimens.

Houston, Texas

Hear when a new Growth Hormone Treatment trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.